Now, enjoy the good life every day!

RSSRSS FEEDS
PODPODCASTS



RealMoney.com: Jim Cramer Blog
Print This Story

Europe Is Starting to Eye U.S. Gems

By Jim Cramer
RealMoney.com Columnist

5/8/2008 8:12 AM EDT
Click here for more stories by Jim Cramer
 

There's always been a groupthink in Europe about currencies. The companies that want to buy American companies have, at times, seemed to care more about the currency, or at least not buying a company in a country whose currency is in decline, than they care about the actual target.

Wait! This offer is too good to turn down! Get this FREE deal now!
 
That's what it looks like now that a large German company and now a large Italian company have decided to start splurging. It is no coincidence that Deutsche Tel (DT - commentary - Cramer's Take) and Finmeccanica are exploring Sprint (S - commentary - Cramer's Take) and DRS (DRS - commentary - Cramer's Take). These companies are selling for something like 40% off for those bearing euros, and neither potential acquirer has debt problems or subprime issues, so the deals don't have big borrowing problems.

That's what I am thinking about when I see the better-than-expected figures today from Unilever (UL - commentary - Cramer's Take) and the other day from Nestle. These companies are part of that same groupthink. They are looking, no doubt, at a Heinz (HNZ - commentary - Cramer's Take) and thinking, "Wait, that's about a $10 billion company that's a global leader."

Or how about Allergan (AGN - commentary - Cramer's Take)? That was a $20 billion company that is down to $16 billion in dollars and about $12 billion as a translation to euros.

These are just too cheap for these companies to ignore, and much more of a healthy franchise than Sprint and a more important franchise than DRS.

We are all possessed right now with the "imminent" catastrophe of someone -- Citi (C - commentary - Cramer's Take), Cerberus, ResMed (RMD - commentary - Cramer's Take)? Somebody.

And those worries have continued to put a lid on many of our valuations. That, plus the subtle part of the slowdown -- botox use not accelerating that fast and breast augmentation slowing down in the U.S., as Allergan said to me last night on "Mad Money" -- makes people too nervous about some solid, non-financial situations.

Yesterday was really ugly. But this market doesn't have much of a memory. Go back over the franchises with great brands that have been crushed both here in stock and there in currency.

These are no longer going to be needles in a haystack.

Random musings: Like Quanta (PWR - commentary - Cramer's Take), a sleeper that I liked for utilities, Willbros (WG - commentary - Cramer's Take) -- a company that I was harping on as way too cheap and brought the CEO on "Mad Money" to bolster my case -- finally delivered the blowout I was looking for. I can understand anyone's desire to take profits on PWR or WG if you bought them at my direction, but these are really just "first good quarter" stocks, and I believe there is more ahead.

At the time of publication, Cramer had no positions in the stocks mentioned.




 RELATED STORIES

Jim Cramer Blog
These Stocks Know Which Way the Wind Blows
5/7/2008 4:30 PM EDT
Wind power is a true emerging theme, and a pullback is the right time to tilt at windmills.

Jim Cramer Blog
Cycle of Financing the Banks Begins Again
5/7/2008 2:57 PM EDT
Without the shorts in place, these look headed lower once more.

Jim Cramer Blog
Without the Shorts, the Bulls Are in Trouble
5/7/2008 1:18 PM EDT
Covering has provided a lot of lift, and the surge may be running out of steam.



Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here.

TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com.




Partner Center


Advertisement



Write us!
Order reprints of TSC articles.

Investor Relations | Privacy Policy | Terms of Use | Conflicts Policy | Corrections | Internet Index | Advertise | FAQ
Site Map | Who's Who | Reader Feedback | Employment | Contact Us
RSSSubscribe to our RSS Feed
© 1996- TheStreet.com, Inc. All rights reserved.
TheStreet.com's enterprise databases running Oracle are professionally monitored and managed by Pythian Remote DBA.